MilliporeSigma · 1 week ago
Document Control Quality Assurance Specialist (Translation)
MilliporeSigma is a global leader in science and technology, and they are seeking a Document Control Quality Assurance Specialist to support translation activities within their documentation system. The role involves managing document creation, revision, distribution, and archiving while ensuring compliance with regulatory requirements for translated documentation.
BiotechnologyMedicalMedical Device
Responsibilities
Maintain a comprehensive document control system
Proofread and review translations using electronic management systems
Build a localized memory bank of translation terms
Maintain a linguistics guide for translators to reference
Organize and maintain digital translation certificates
Control the issuance, distribution, and retrieval of documents
Manage electronic and physical document repositories
Collaborate with various departments to ensure document accuracy and availability
Qualification
Required
Bachelor's Degree in Translations, Linguistics, Modern Languages or Biology, Chemistry, Microbiology or other scientific discipline
1+ years experience of web-based translation management systems and electronic document management systems (linguistics guide)
Preferred
Experience in quality documentation and/or learning management systems
Highly developed interpersonal, written, and verbal communication skills
Ability to establish collaborative relationships with various departments to deliver on quality commitments
Ability to work autonomously, effectively manage time and deliver results on time
Strong problem-solving skills
Strong computer skills, including Microsoft Office and quality systems software
Understanding or experience with ISO & FDA regulations
Professional fluency in one of the following: French, Spanish or German
Benefits
Health insurance
Paid time off (PTO)
Retirement contributions
Other perquisites
Company
MilliporeSigma
Together with our colleagues, customers and stakeholders, we impact life and health with science.
Funding
Current Stage
Late StageRecent News
2025-09-23
2025-06-20
Company data provided by crunchbase